Camlin Fine Sciences share news and announcements
NSE: CAMLINFINEBSE: 532834Chemicals & PetrochemicalsSmall Cap
Last close ₹80.53down ₹3.23 (3.86%)BSE ₹80.36
Share price at the NSE close on 23 Oct 2026. Previous close ₹83.76.
52-week range of traded prices to 23 Oct 2026
₹78.80Low, 23 Oct 2026₹204.57High, 23 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹1,547 Cr1,056th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 11 Aug 2026
- 263.0
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹29 crore of one-off items, the largest of them in the quarter to Mar 2026.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 26 May 2026
- 1.5
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 11 Aug 2026
- 0.6%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹29 crore of one-off items, the largest of them in the quarter to Mar 2026.
- −2.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 11 Aug 2026
- 0.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 26 May 2026
- 0.67
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 7,32,39442.1% delivered
Camlin Fine Sciences share news and announcements
645 announcements, routine notices left out, newest first. Page 12 of 13.
Nov 2017
Oct 2017
24 Oct · Disclosure
Sep 2017
29 Sep · Disclosure
Aug 2017
28 Aug · Board meeting
Jul 2017
Jun 2017
May 2017
22 May · Legal
Exchange has sought clarification from Camlin Fine Sciences Limited with respect to announcement dated 19-May-2017, regarding "Camlin Fine Sciences Limited has informed the Exchange regarding Outcome of Board Meeting held on May 19, 2017.". On basis of above the Company is required to clarify following: 1. Brief profile (in case of appointment);The response of the Company is awaited.19 May · Board meeting
Apr 2017
Mar 2017
2 Mar · Disclosure
Feb 2017
10 Feb · Board meeting
Jan 2017
Dec 2016
Nov 2016
24 Nov · News Verification
Exchange has sought clarification from Camlin Fine Sciences Limited with respect to recent news item captioned "Fairfax in talks to buy controlling stake in Camlin Fine Sciences." In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such negotiations were taking place and b) Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.
Oct 2016
Sep 2016
Aug 2016
12 Aug · Regulation 44(3) of SEBI (LODR), Reg., 2015
Jul 2016
Jun 2016